Commercial vendors will happily sell you almost any Congressional Research Service report issued in the last decade, making CRS secrecy profitable for some but otherwise pointless. Yet Congress has stubbornly told the CRS not to make its reports directly available to the taxpaying public, who have already paid for them once.
Some recent CRS reports that are not otherwise freely available in public databases include the following (all pdf).
“Steel: Price and Policy Issues,” updated August 31, 2006.
“U.S. Strategic Nuclear Forces: Background, Developments, and Issues,” September 8, 2006.
“Federal Counter-Terrorism Training: Issues for Congressional Oversight,” August 31, 2006.
“Navy Aircraft Carriers: Proposed Retirement of USS John F. Kennedy — Issues and Options for Congress,” updated August 29, 2006.
“Free Mail for Troops Overseas,” updated August 22, 2006.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.